FDA Approves Alhemo® Injection As Once-Daily Prophylactic Treatment To Prevent Or Reduce The Frequency Of Bleeding ...
(MENAFN- PR Newswire) FDA approval is based on data from the pivotal phase 3 trial (explorer7) establishing the safety and efficacy of Alhemo® for daily prevention of bleeds in adults and pediatric patients 12 years of age and older living with hemophilia …